Key result
Inhibition of TAK1 significantly decreased myocardial ischaemia/reperfusion-induced myocardial infarction area, reduced cell death, and improved cardiac function in mice and primary cardiomyocytes.
Why the study?
TAK1 regulates cell death and biological responses, but its role in acute myocardial ischaemia/reperfusion injury is unknown.
Does TAK1 inhibition reduce myocardial ischemia/reperfusion injury in preclinical models?
Does TAK1 inhibition reduce myocardial ischemia/reperfusion injury in preclinical models?
Inhibition of TAK1 mitigates myocardial ischemia/reperfusion injury by suppressing ROS and endoplasmic reticulum stress, suggesting a potential therapeutic target.
TAK1 inhibition merits further preclinical exploration in ischemia/reperfusion injury; hypothesis-generating and not ready for clinical translation.
Transforming growth factor β-activated protein kinase 1 (TAK1) involves in various biological responses and is a key regulator of cell death. However, the role of TAK1 on acute myocardial ischaemia/reperfusion (MI/R) injury is unknown. We observed that TAK1 activation increased significantly after MI/R and hypoxia/reoxygenation (H/R), and we hypothesized that TAK1 has an important role in MI/R injury. Mice (TAK1 inhibiting by 5Z-7-oxozeaenol or silencing by AAV9 vector) were exposed to MI/R injury. Primary cardiomyocytes (TAK1 silencing by siRNA; and overexpressing TAK1 by adenovirus vector) were used to induce H/R injury model in vitro. Inhibition of TAK1 significantly decreased MI/R-induced myocardial infarction area, reduced cell death and improved cardiac function. Mechanistically, TAK1 silencing suppressed MI/R-induced myocardial oxidative stress and attenuated endoplasmic reticulum (ER) stress both in vitro and in vivo. In addition, the inhibition of ROS by NAC partially reversed the damage of TAK1 in vitro. Our study presents the first direct evidence that inhibition of TAK1 mitigated MI/R injury, and TAK1 mediated ROS/ER stress/apoptosis signal pathway is important for the pathogenesis of MI/R injury.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2020) studied Myocardial ischaemia/reperfusion injury. TAK1 inhibition was evaluated on Myocardial infarction area, cell death, and cardiac function. Inhibition of TAK1 significantly decreased myocardial ischaemia/reperfusion-induced myocardial infarction area, reduced cell death, and improved cardiac function in mice and primary cardiomyocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: